Pharmacist-led transition of care in the emergency department

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a small randomized pilot comparing usual ED discharge care to usual care plus a multi‑faceted pharmacist-led transition of care program at Al‑Wakra Hospital. Eligible adults discharged home are randomized to receive either standard discharge processes or additional pharmacist services including review of discharge prescriptions, medication list reconciliation, and targeted medication education. The trial focuses on feasibility and implementation outcomes to determine whether the program can be delivered reliably in the emergency department setting. Results will inform whether a larger definitive trial should be conducted.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults (aged 18 years or more) discharged from the ED with at least one of the following:
* Polypharmacy: Five or more scheduled prescription medications for chronic illnesses (i.e., chronic maintenance medications, even if such medications were not refilled during the index ED visit)
* Discharged with a new prescription of high-risk medication, including:
* Drugs with the potential of withdrawal symptoms upon abrupt discontinuation such as antipsychotics, antiepileptics, antidepressants, and tapering glucocorticoids.
* Insulin (initiation or intensification of therapy)
* Oral hypoglycemic agents
* Visiting ED for an exacerbation of chronic illness (e.g., exacerbation of asthma, COPD, CHF, uncontrolled diabetes mellitus, hypertension urgency, uncontrolled epilepsy)

Exclusion Criteria:

* The following patients will be excluded:
* Presenting with acute minor illnesses
* Lack of decision-making capacity (including documented moderate or severe dementia, altered mental status, unstable psychiatric illness, altered consciousness level, lack of orientation to person/place/time as reported in EHR, delirium, patients seen in the ED for a psychiatric evaluation)
* Language barrier, i.e., inability to communicate in either English or Arabic as the intervention will be provided by English/Arabic speaking clinical pharmacists
* Expected length of stay in Qatar of \<30 days post discharge (including transit passengers)
* Substance use disorders (e.g., alcoholism, opioid dependency) or drug-seeking behavior, as reported in EHR
* Prisoners who are serving an active sentence
* Patients presenting for non-medical, socially driven reasons (e.g., seeking shelter, support, or resources) with no identifiable acute medical condition, and known to the ED team as recurrent visitors.
* Discharge to a location other than home (e.g., patients transferred to another hospital, long-term or skilled nursing facility)
* Study pharmacists unavailable to deliver the intervention if the patients were randomized to the intervention arm
* Pregnant women
* Patients seen for trauma or planned surgery
* Terminally ill patients
* Patients discharged from ED with watchful waiting (e.g., expected to be readmitted for an intervention such as surgical intervention if conservative management failed)
* Patients who are admitted to the hospital after enrollment (i.e., following consent but prior to ED discharge)

Where it's running

• Al- Wakra Hospital- Hamad Medical Corporation
  Al Wakrah, Qatar Recruiting

Study contacts

• Study coordinator: Muhammad Abdul Hadi, PhD
• Email: mabdulhadi@qu.edu.qa
• Phone: 0097433114549

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• New care pathways to support transition from hospital to home using AI and digital help

  A digital remote monitoring system is tested to see if it can help older adults with multiple health issues avoid readmission within 30 days after leaving the hospital.

  Recruiting at 3 sites Istituto Nazionale di Ricovero e Cura per Anziani · Ancona and 2 other locations · NCT07731126

• Hospital-to-home support for children and youth with special health care needs

  This trial tests whether a single post-discharge phone call or weekly phone calls for a month better help hospitalized children and youth with special health care needs and their parents reduce acute care use and increase parent confidence.

  Recruiting at 2 sites Duke University · Chapel Hill, North Carolina and 1 other locations · NCT06428175

• Transitional care program for stroke patients with hemiplegia

  This study tests a new care program for stroke patients with hemiplegia to see if it helps them take better care of themselves, improves their quality of life, and reduces hospital visits after they leave the hospital.

  Recruiting Mahidol University · Bang Kho Laem, Bangkok · NCT06242366

• BL-M07D1: T-bren vs standard platinum chemo for HER2-expressing metastatic urothelial cancer after anti-PD-(L)1 therapy

  This trial tests whether T-bren can help people with HER2-expressing metastatic urothelial cancer who progressed after anti-PD-(L)1 therapy, compared with standard platinum-based chemotherapy.

  Recruiting at 2 sites Phase 3 SystImmune Inc. · Macon, Georgia and 1 other locations · NCT07869836

• Intravesical UGN-501 for Recurrent NMIBC (Phase 1, dose-escalation)

  This study tests whether UGN-501 can be safely given into the bladder to treat adults with recurrent non-muscle invasive bladder cancer.

  Recruiting at 6 sites Phase 1 UroGen Pharma Ltd. · Queen Creek, Arizona and 14 other locations · NCT07725796

• Is ongoing systemic immunotherapy needed after achieving tumor-free status in very-high-risk NMIBC?

  This study tests whether patients who have become tumor-free after a systemic immunotherapy-based bladder-sparing treatment can safely stop therapy and instead be watched closely.

  Recruiting at 4 sites Phase 2 Tianjin Medical University Second Hospital · Tianjin and 3 other locations · NCT07625527

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.